Leap Therapeutics Inc. (LPTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Leap Therapeutics Inc.

    NASDAQ: LPTX · Real-Time Price · USD
    0.53
    -0.20 (-27.40%)
    At close: Oct 03, 2025, 3:59 PM
    0.53
    -0.32%
    Pre-market: Oct 06, 2025, 06:29 AM EDT

    Leap Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.6 -1.04 -0.93 -6.85
    PEG Ratio
    		 0.03 0.06 -0.49 -3.53
    PS Ratio
    		 n/a n/a n/a 185.38
    PB Ratio
    		 3.09 1.41 0.87 2.58
    P/FCF Ratio
    		 -1.79 -1.93 -1.04 -7.91
    P/OCF Ratio
    		 -1.79 -1.93 -1.04 -7.91
    OCF/S Ratio
    		 n/a n/a n/a -23.44
    Debt / Equity Ratio
    		 0.01 0.00 0.01 0.00
    Quick Ratio
    		 3.41 5.64 6.05 11.70
    Current Ratio
    		 3.41 5.64 6.05 11.70
    Asset Turnover
    		 n/a n/a n/a 0.01
    Interest Coverage
    		 n/a n/a -1.05K -1.01K
    Return on Equity
    		 -1.93 -1.35 -0.93 -0.38
    Return on Assets
    		 -1.38 -1.12 -0.78 -0.34
    Return on Invested Capital
    		 -2 -1.44 -0.95 -0.38
    Dividend Yield
    		 0.00 n/a n/a n/a
    Payout Ratio
    		 -0.00 n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a 1.00
    Net Profit Margin
    		 n/a n/a n/a -27.06
    Pretax Profit Margin
    		 n/a n/a n/a -27.07
    Operating Profit Margin
    		 n/a n/a n/a -27.62
    FCF Margin
    		 n/a n/a n/a -23.44
    EBITDA Margin
    		 n/a n/a n/a -26.68

    Add to Watchlist